Author:
Liu Weijian,Xu Yuxiang,Yang Liangzi,Zhan Senlin,Pang Kaihua,Lin Hao,Qin Hongjuan,Zhang Peize
Abstract
AbstractPulmonary tuberculosis (TB) can result in irreversible damage and lead to tuberculous destructive lung (TDL), a severe chronic lung disease that is associated with a high mortality rate. Additionally, pulmonary hypertension (PH) is a hemodynamic disorder that can be caused by lung diseases. The objective of this study is to investigate the risk factors associated with PH in active TB patients diagnosed with TDL. We conducted a retrospective review of the medical records of 237 patients who were diagnosed with TDL, active pulmonary tuberculosis, and underwent echocardiography at the Third People’ Hospital of Shenzhen from January 1, 2016, to June 30, 2023. Univariate and multivariate logistic regression analyses were performed to identify factors that correlated with the development of pulmonary hypertension. Univariate and multivariate logistic regression analyses revealed that several factors were associated with an increased risk of pulmonary hypertension (PH) in individuals with tuberculosis destroyed lung (TDL). These factors included age (OR = 1.055), dyspnea (OR = 10.728), D-dimer (OR = 1.27), PaCO2 (OR = 1.040), number of destroyed lung lobes (OR = 5.584), bronchiectasis (OR = 3.205), and chronic pleuritis (OR = 2.841). When age, D-dimer, PaCO2, and number of destroyed lung lobes were combined, the predictive value for PH in patients with TDL was found to be 80.6% (95% CI 0.739–0.873),with a sensitivity of 76.6% and specificity of 73.2%. Advanced age, elevated D-dimer levels, hypercapnia, and severe lung damage were strongly correlated with the onset of PH in individuals with active pulmonary tuberculosis (PTB) and TDL. Furthermore, a model incorporating age, D-dimer, PaCO2, and the number of destroyed lung lobes might be valuable in predicting the occurrence of PH in patients with active PTB and TDL.
Funder
Technology Project of Guangdong Province
Shenzhen Science and Technology Plan Project
Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. World Health Organization. Global Tuberculosis Report 2022 (World Health Organization, 2022).
2. Kim, H. Y. et al. Thoracic sequelae and complications of tuberculosis. Radiographics 21(4), 839–858. https://doi.org/10.1148/radiographics.21.4.g01jl06839 (2001) (Epub 2001/07/14).
3. Ryu, Y. J., Lee, J. H., Chun, E. M., Chang, J. H. & Shim, S. S. Clinical outcomes and prognostic factors in patients with tuberculous destroyed lung. Int. J. Tuberc. Lung Dis. 15(2), 246–250 (2011) (Epub 2011/01/12).
4. Mandras, S. A., Mehta, H. S. & Vaidya, A. Pulmonary hypertension: A brief guide for clinicians. Mayo Clin Proc. 95(9), 1978–1988. https://doi.org/10.1016/j.mayocp.2020.04.039 (2020) (Epub 2020/08/31).
5. Galiè, N. et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur. Respir. J. 46(4), 903–975. https://doi.org/10.1183/13993003.01032-2015 (2015) (Epub 2015/09/01).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献